Liquidia Corp. (LQDA)
28.64
+0.65
(+2.32%)
USD |
NASDAQ |
Oct 02, 16:00
28.49
-0.15
(-0.52%)
After-Hours: 20:00
Liquidia EPS Diluted (Quarterly) : 0.7369 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7369 |
| March 31, 2026 | 0.5228 |
| December 31, 2025 | 0.1455 |
| September 30, 2025 | -0.0409 |
| June 30, 2025 | -0.4858 |
| March 31, 2025 | -0.4505 |
| December 31, 2024 | -0.4547 |
| September 30, 2024 | -0.3962 |
| June 30, 2024 | -0.3751 |
| March 31, 2024 | -0.399 |
| December 31, 2023 | -0.4196 |
| September 30, 2023 | -0.2435 |
| June 30, 2023 | -0.363 |
| March 31, 2023 | -0.1816 |
| December 31, 2022 | -0.1013 |
| September 30, 2022 | -0.141 |
| June 30, 2022 | -0.1519 |
| March 31, 2022 | -0.3039 |
| December 31, 2021 | -0.2211 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1398 |
| June 30, 2021 | -0.1288 |
| March 31, 2021 | -0.2114 |
| December 31, 2020 | -0.3804 |
| September 30, 2020 | -0.3965 |
| June 30, 2020 | -0.4886 |
| March 31, 2020 | -0.5203 |
| December 31, 2019 | -0.7119 |
| September 30, 2019 | -0.7156 |
| June 30, 2019 | -0.3147 |
| March 31, 2019 | -0.8584 |
| December 31, 2018 | -0.6172 |
| September 30, 2018 | -0.8334 |
| June 30, 2018 | -0.5857 |
| March 31, 2018 | -1.741 |
| December 31, 2017 | 0.5197 |
| September 30, 2017 | -34.91 |
| June 30, 2017 | -0.5249 |
| March 31, 2017 | -0.6227 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harmony Biosciences Holdings, Inc. | 1.284 |
| Johnson & Johnson | 2.268 |
| United Therapeutics Corp. | 7.271 |
| Amneal Pharmaceuticals, Inc. | 0.1757 |
| Pfizer Inc. | -0.0435 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 74.72M |
| Revenue (Quarterly) | 171.68M |
| Total Expenses (Quarterly) | 96.96M |
| Enterprise Value | 2.451B |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | 43.52% |
| Earnings Yield | 4.76% |
| Operating Earnings Yield | 6.05% |
| Normalized Earnings Yield | 4.764 |